TRIAMCINOLONE ACETONIDE INJECTABLE SUSPE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F8005 for the delivery of TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION, identified by NSN 6505011467792 and PR 7017618353. The total contract value is $67.60, with the award issued on July 23, 2026, and it is a delivery order placed under the master contract SPE2DX25D9900. The item is intended for federal use under the Department of Defense, with performance location unspecified but within the United States. The awardee, identified by CAGE code 1UNB0, is the sole provider for this specific pharmaceutical supply. No set-aside type or NAICS code is designated, and the procurement is handled directly by the DLA without publicly listed point of contact information. The award notice is accessible via the DIBBS portal using the provided UI link.
General Info
Agency
Contract Value
$67.6NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
